2014

Dataram Announces Sale of up to $6.5 Million Series A Preferred Stock and Set …MarketWatch… (the “Purchase Agreement”), pursuant to which the Company agreed to sell up to an aggregate of 1,300,000 shares of its Series A Preferred Stock (the “Series A Stock”) together with warrants to purchase shares of common stock, to such investors […]

Dataram Announces Sale of up to $6.5 Million Series A Preferred Stock and Set …Business Wire (press release)… (the “Purchase Agreement”), pursuant to which the Company agreed to sell up to an aggregate of 1,300,000 shares of its Series A Preferred Stock (the “Series A Stock”) together with warrants to purchase shares of common stock,

Sector Update: Energy Stocks Still Padding Out-Sized Advance; MagneGas …NASDAQThe offering also will include 940 unregistered shares of the company’s Series D-2 convertible preferred stock, with each preferred share convertible into 1,000 shares of common stock and raising $940,000 in gross proceeds. MNGA also will issue … and more …read more

Sector Update: Health Care Stocks Keeping Pace With Broader Markets …NASDAQHealth care stocks were higher in mid-day trade, with the NYSE Health Care Sector Index climbing about 1.7% and shares of health care companies in the S&P 500 up 1.4% as a group. In company news, Illumina ( ILMN ) rose Tuesday after the genetic

Sector Update: Health CareNASDAQILMN shares were up more than 8% at $178.16 each, earlier climbing to an intra-day high of $180.80 a share. The stock has traded within a 52-week range of $80.88 to $185.00 a share, rising 101% over the past 12 months through Monday’s close. …read more

CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and …PharmiWeb.com (press release)CEL-SCI Corporation (NYSE MKT: CVM) a late-stage oncology company today announced that it has priced a “best efforts” underwritten public offering of common stock and warrants at a combined price of $0.76 for aggregate gross proceeds of $6 million …CEL-SCI To Raise

CEL-SCI To Raise $1 Mln In Registered Direct Offering – Quick FactsNASDAQ(RTTNews.com) – CEL-SCI Corp. ( CVM ), a late-stage oncology company, Tuesday said it has agreed to sell common stock and warrants in a registered direct offering to European investors at a combined price of $0.76 for aggregate gross proceeds of a … and